Exchange: NASDAQ·Updated 07:30 PM EDT

IMAB I-Mab - ADR

$1.43
$0.125
(9.62%)
Today
Closed $1.43
$0.0035
(0.25%)
After Hours
EarningsMar 8
Mkt Cap$150.8M
Vol657,925.00

About IMAB

NovaBridge Biosciences operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
56

Bullish Sentiment

How do you feel about IMAB?

Stocksman45
$IMAB ESMO 2026 Givastomig Phase 1b results will be announced October 25th. Could be a big catalyst if positive.
LabPsycho
$IMAB Posted this when IMAB much higher several months ago - thought it was going down and possibly to 1.2 by Nov. Right on track so far.

Advertisement|Remove ads.